QDx Pathology to Market Mitomics' PCR-Based Mitochondrial DNA Prostate Cancer Test in US

The test, which QDx Pathology will market under the name QPredict Prostate Mitomic Test, is based on Mitomics' currently marketed Prostate Core Mitomic Test.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.